76 related articles for article (PubMed ID: 24907907)
1. Vaccination with DKK1-derived peptides promotes bone formation and bone mass in an aged mouse osteoporosis model.
Wu Q; Li RS; Zhao Y; Wang ZX; Tang YC; Zhang J; Liu JN; Tan XY
Calcif Tissue Int; 2014 Aug; 95(2):153-65. PubMed ID: 24907907
[TBL] [Abstract][Full Text] [Related]
2. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
Morvan F; Boulukos K; Clément-Lacroix P; Roman Roman S; Suc-Royer I; Vayssière B; Ammann P; Martin P; Pinho S; Pognonec P; Mollat P; Niehrs C; Baron R; Rawadi G
J Bone Miner Res; 2006 Jun; 21(6):934-45. PubMed ID: 16753024
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss.
Wang FS; Ko JY; Yeh DW; Ke HC; Wu HL
Endocrinology; 2008 Apr; 149(4):1793-801. PubMed ID: 18174290
[TBL] [Abstract][Full Text] [Related]
4. [Anti-Dickkopf1 (Dkk1) antibody as a bone anabolic agent for the treatment of osteoporosis].
Tai N; Inoue D
Clin Calcium; 2014 Jan; 24(1):75-83. PubMed ID: 24369283
[TBL] [Abstract][Full Text] [Related]
5. Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases.
Ke HZ; Richards WG; Li X; Ominsky MS
Endocr Rev; 2012 Oct; 33(5):747-83. PubMed ID: 22723594
[TBL] [Abstract][Full Text] [Related]
6. A rate-limiting role for Dickkopf-1 in bone formation and the remediation of bone loss in mouse and primate models of postmenopausal osteoporosis by an experimental therapeutic antibody.
Glantschnig H; Scott K; Hampton R; Wei N; McCracken P; Nantermet P; Zhao JZ; Vitelli S; Huang L; Haytko P; Lu P; Fisher JE; Sandhu P; Cook J; Williams D; Strohl W; Flores O; Kimmel D; Wang F; An Z
J Pharmacol Exp Ther; 2011 Aug; 338(2):568-78. PubMed ID: 21531794
[TBL] [Abstract][Full Text] [Related]
7. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
8. Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab.
Gatti D; Viapiana O; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Adami S; Rossini M
J Bone Miner Res; 2012 Nov; 27(11):2259-63. PubMed ID: 22692843
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI
J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584
[TBL] [Abstract][Full Text] [Related]
10. Dkk1 haploinsufficiency requires expression of Bmp2 for bone anabolic activity.
Intini G; Nyman JS
Bone; 2015 Jun; 75():151-60. PubMed ID: 25603465
[TBL] [Abstract][Full Text] [Related]
11. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
12. Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury.
Li X; Grisanti M; Fan W; Asuncion FJ; Tan HL; Dwyer D; Han CY; Yu L; Lee J; Lee E; Barrero M; Kurimoto P; Niu QT; Geng Z; Winters A; Horan T; Steavenson S; Jacobsen F; Chen Q; Haldankar R; Lavallee J; Tipton B; Daris M; Sheng J; Lu HS; Daris K; Deshpande R; Valente EG; Salimi-Moosavi H; Kostenuik PJ; Li J; Liu M; Li C; Lacey DL; Simonet WS; Ke HZ; Babij P; Stolina M; Ominsky MS; Richards WG
J Bone Miner Res; 2011 Nov; 26(11):2610-21. PubMed ID: 21773994
[TBL] [Abstract][Full Text] [Related]
13. Bone mass is inversely proportional to Dkk1 levels in mice.
MacDonald BT; Joiner DM; Oyserman SM; Sharma P; Goldstein SA; He X; Hauschka PV
Bone; 2007 Sep; 41(3):331-9. PubMed ID: 17613296
[TBL] [Abstract][Full Text] [Related]
14. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
[TBL] [Abstract][Full Text] [Related]
15. Homozygous Dkk1 Knockout Mice Exhibit High Bone Mass Phenotype Due to Increased Bone Formation.
McDonald MM; Morse A; Schindeler A; Mikulec K; Peacock L; Cheng T; Bobyn J; Lee L; Baldock PA; Croucher PI; Tam PPL; Little DG
Calcif Tissue Int; 2018 Jan; 102(1):105-116. PubMed ID: 29105022
[TBL] [Abstract][Full Text] [Related]
16. Advanced molecular profiling in vivo detects novel function of dickkopf-3 in the regulation of bone formation.
Aslan H; Ravid-Amir O; Clancy BM; Rezvankhah S; Pittman D; Pelled G; Turgeman G; Zilberman Y; Gazit Z; Hoffmann A; Gross G; Domany E; Gazit D
J Bone Miner Res; 2006 Dec; 21(12):1935-45. PubMed ID: 17002559
[TBL] [Abstract][Full Text] [Related]
17. Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo.
Glantschnig H; Hampton RA; Lu P; Zhao JZ; Vitelli S; Huang L; Haytko P; Cusick T; Ireland C; Jarantow SW; Ernst R; Wei N; Nantermet P; Scott KR; Fisher JE; Talamo F; Orsatti L; Reszka AA; Sandhu P; Kimmel D; Flores O; Strohl W; An Z; Wang F
J Biol Chem; 2010 Dec; 285(51):40135-47. PubMed ID: 20929859
[TBL] [Abstract][Full Text] [Related]
18. Pomegranate seed oil prevents bone loss in a mice model of osteoporosis, through osteoblastic stimulation, osteoclastic inhibition and decreased inflammatory status.
Spilmont M; Léotoing L; Davicco MJ; Lebecque P; Mercier S; Miot-Noirault E; Pilet P; Rios L; Wittrant Y; Coxam V
J Nutr Biochem; 2013 Nov; 24(11):1840-8. PubMed ID: 23953990
[TBL] [Abstract][Full Text] [Related]
19. Designation of a novel DKK1 multiepitope DNA vaccine and inhibition of bone loss in collagen-induced arthritic mice.
Zhang X; Liu S; Li S; Du Y; Dou Y; Li Z; Yuan H; Zhao W
Biomed Res Int; 2015; 2015():765490. PubMed ID: 26075259
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
Li X; Ominsky MS; Warmington KS; Morony S; Gong J; Cao J; Gao Y; Shalhoub V; Tipton B; Haldankar R; Chen Q; Winters A; Boone T; Geng Z; Niu QT; Ke HZ; Kostenuik PJ; Simonet WS; Lacey DL; Paszty C
J Bone Miner Res; 2009 Apr; 24(4):578-88. PubMed ID: 19049336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
